Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Wyze Biotech Closes A Rounds with $30 Million for Universal Immune Cell Products

publication date: Aug 18, 2022

Guangdong Wyze Biotech closed a $9 million Series A+ financing to develop its off-the-shelf immune cell products based on double-negative T cells (DNT). Wyze completed a $21.5 million Series A funding in 2021. DNT cells are a relatively rare subset of peripheral T cells (about 5%) that are CD3 positive but CD4 and CD8 negative. Wyze expects them to be effective therapies for inflammation, immune disease and cancer indications. In late 2021, the company was approved to start a China Phase I trial of its lead DNT therapy in r/r acute myelogenous leukemia patients. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here